Recruiting

AR/VR Application for Pain Relief in Renal Colic Patients

0 criteria met from your profileSee at a glance how your profile meets each eligibility criteria.
What is being tested

Commercial AR/VR Headset with Calming App

+ Pharmacologic Standard of Care Alone

DeviceOther
Who is being recruted

Urogenital Diseases+14

+ Calculi

+ Colic

Over 18 Years
See all eligibility criteria
How is the trial designed

Treatment Study

Interventional
Study Start: April 2025
See protocol details

Summary

Principal SponsorCommunity Medical Center, Toms River, NJ
Study ContactGreg Neyman, MD
Last updated: December 11, 2025
Sourced from a government-validated database.Claim as a partner

Study start date: April 1, 2025

Actual date on which the first participant was enrolled.

This study focuses on patients who visit the emergency department (ED) with symptoms of renal colic, a severe type of pain caused by kidney stones. The aim is to explore whether using a virtual or augmented reality (VR/AR) calming application, in addition to the usual pain medications, can help reduce the discomfort experienced by these patients. Kidney stones can be extremely painful, and finding new ways to alleviate this pain could significantly improve patient care and comfort. Participants in this study are divided into two groups. One group receives the standard pain relief medication typically used for kidney stones. The other group receives the same medication along with a calming VR/AR experience using a headset. The study evaluates whether the additional use of VR/AR technology helps in managing pain more effectively than medication alone. There are no specific risks mentioned, but the potential benefit is a more comfortable experience for patients during their ED visit.

Official TitleThe Use of AR / VR in Patients Presenting to the ED With Renal Colic 
Principal SponsorCommunity Medical Center, Toms River, NJ
Study ContactGreg Neyman, MD
Last updated: December 11, 2025
Sourced from a government-validated database.Claim as a partner

Protocol

This section provides details of the study plan, including how the study is designed and what the study is measuring.
Design Details

92 patients to be enrolled

Total number of participants that the clinical trial aims to recruit.

Treatment Study

These studies test new ways to treat a disease, condition, or health issue. The goal is to see if a new drug, therapy, or approach works better or has fewer side effects than existing options.



Eligibility

Researchers look for people who fit a certain description, called eligibility criteria: person's general health condition or prior treatments.
Conditions
Criteria

Any sex

Biological sex of participants that are eligible to enroll.

Over 18 Years

Range of ages for which participants are eligible to join.

Healthy volunteers not allowed

If individuals who are healthy and do not have the condition being studied can participate.

Conditions

Pathology

Urogenital DiseasesCalculiColicFemale Urogenital Diseases and Pregnancy ComplicationsInfant, Newborn, DiseasesKidney CalculiKidney DiseasesNeurologic ManifestationsPainUrinary CalculiUrologic DiseasesPathological Conditions, AnatomicalFemale Urogenital DiseasesMale Urogenital DiseasesUrolithiasisNephrolithiasisRenal Colic

Criteria

Inclusion Criteria: * Patient self-reported history of nephrolithiasis * Subjective history suggesting that current presentation is similar to past presentations of nephrolithiasis (character, quality, location, intensity of pain; previous surgical intervention or lithotripsy) * Patients with self-reported moderate to severe pain on the visual pain scale determined as greater than 5/10 * Normal vital signs (afebrile) * Agreeable to informed consent as dictated by IRB and local practice * No contraindications to standard therapy (ie fluids, NSAIDs, opioids, etc.) * Compliance with the virtual reality treatment * Keeps the headset on for the duration of the experience * Understands the instructions Exclusion Criteria: * Age \< 18 years * Pregnant * Individuals with chronic pain conditions such as fibromyalgia (chronic pain may confound results, as patients may have higher than baseline pain levels affecting their response to medications) * Individuals with severe anxiety or claustrophobia * Individuals with severe motion sickness or previous episodes of motion sickness due to VR (those who may not react well to the VR experience) * Individuals with GFR\<60 or previous documented diagnosis of CKD as they may not be suitable candidate for traditional analgesia * Individuals with previous opioid dependence * Requirement of immediate surgery (obstructing calculi with concomitant urinary tract infection) * Patients with diagnoses meeting admission criteria (sepsis, MI) * Audio/visual impairment (unable to appreciate stimuli provided by the headset) * Patients administered opiates as the first line pain control medication will not be included in final data collection, as opioid administration may result in difficulty consenting and understanding the study protocol / design

Study Plan

Find out more about all the medication administered in this study, their detailed description and what they involve.
Treatment Groups
Study Objectives

2 intervention groups are designated in this study

This study does not include a placebo group 

Treatment Groups

Group I

Experimental
Patients receive adjunct AR Calming App via commercial AR/VR headset in addition to standard of care pharmacologic management at the discretion of the treating provider

Group II

Active Comparator
Patients receive standard of care pharmacologic management at the discretion of the treating provider

Study Objectives

Primary Objectives

Secondary Objectives

Study Centers

These are the hospitals, clinics, or research facilities where the trial is being conducted. You can find the location closest to you and its status.

This study has 1 location

Recruiting

Rutgers Robert Wood Johnson Barnabas Health Community Medical Center

Toms River, United StatesSee the location
Recruiting
One Study Center